The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC).
 
Roisin Eilish O'Cearbhaill
No Relationships to Disclose
 
D. Scott McMeekin
No Relationships to Disclose
 
Gina Mantia-Smaldone
No Relationships to Disclose
 
Camille Gunderson
No Relationships to Disclose
 
Paul Sabbatini
Research Funding - Bristol-Myers Squibb (Inst); Ludwig Institute for Cancer Research (Inst); OncoMed (Inst)
 
Fiore Cattaruzza
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - OncoMed
Travel, Accommodations, Expenses - OncoMed
 
Marcus Fischer
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Ann M. Kapoun
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - co-author of patents filed at OncoMed (Inst)
Travel, Accommodations, Expenses - OncoMed
 
Lu Xu
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Jakob Dupont
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - OncoMed
 
Rainer Karl Brachmann
Employment - Gilead Sciences (I); OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - Gilead Sciences (I); OncoMed
 
Azeez Farooki
Consulting or Advisory Role - Akrimax Pharmaceuticals; Alexion Pharmaceuticals; Amgen; Bayer/Onyx; Celgene; NPS Pharmaceuticals; OncoMed
Speakers' Bureau - Abbott/AbbVie; Merck
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca; Genentech/Roche; Immunogen
Travel, Accommodations, Expenses - Amgen; AstraZeneca